10-10-2026 00:37 via drugs.com

Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers

FRIDAY, Oct. 9, 2026-- Access barriers to specialty oral anticancer medications (SOAMs) for blood cancers include rejection by insurance and high out-of-pocket costs, according to a study published online Sept. 30 in the Journal of Clinical...
Read more »

Pharmaceutical news



'Masked' High Blood Pressure Poses A Fall Risk For Seniors, Study Warns
Eye Injuries From Beauty Products Send Thousands To ER Every Year
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate
Physical Activity Linked to Slower Cognitive, Motor Progression in Parkinson Disease
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Late-Night Snacking May Be Bad For Your Liver
Active Smoking Linked to Progression of Sickle Cell Retinopathy
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Growing Your Own Sprouts? These Broccoli Seeds Are Being Recalled For Salmonella
Don't Trust AI For Blood Pressure Monitor Recommendations, Study Warns
Needle-Shy? Ask Them To Pump Up Your Jam, Study Suggests
New Drug Combo Restores HIV Control
Psilocybin Isn't Seen As Cure-All By People With Depression, Study Finds
Desktop versie